Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

shutterstock 226132561

News and Trends 18 Oct 2016

€4M Grant for a Cancer Vaccine that could Bench its Competitors

Hookipa just secured a huge grant from the Austrian government. The plan is to develop the strongest HPV vaccine ever and claim its place in the €2B head and neck cancer market. Hookipa, one of the hottest Biotechs in Vienna, develops vaccines based on a new class of viral vectors. Its platform has impressed the public sector and secured €4.16M from the Austrian […]

October 18, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 402140419

News and Trends 18 Oct 2016

How can Cultured Meat solve World Hunger and Global Warming?

What is ‘cultured meat’ and how can it address the most pressing global problems? Let us introduce you to some of the brilliant minds behind it. The world’s population is predicted to reach almost 10 billion by 2050, and we don’t have the resources to feed all of them… yet. The meat industry currently uses 70% of […]

October 18, 2016 - 6 minutesmins - By Clara Rodríguez Fernández

signing contract PORTRAIT IMAGES ASIA BY NONWARIT fi

News and Trends 17 Oct 2016

TxCell lines up another duck in its CAR-Treg campaign

Novartis veteran Li Zhou has joined TxCell as the VP of cell engineering to oversee CAR-Treg programs for autoimmune and inflammation diseases. The French Treg maverick, TxCell, has hoovered up more talent to pioneer its hybrid CAR-Treg therapies: Li Zhou will be the new Vice President of the company’s cell engineering division. What we are doing here with CAR-Tregs to treat […]

October 17, 2016 - 2 minutesmins - By Evelyn Warner

shutterstock 495585322

News and Trends 17 Oct 2016

Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize

Just after the Nobel Prize was awarded to the study of autophagy, PhoreMost announces a collaboration to target the process in neurodegenerative diseases. PhoreMost is a drug discovery company that focuses on finding ‘undruggable’ targets, such as the KRAS cancer gene. Now, the company has announced a collaboration with the University of Cambridge to start working […]

October 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

chimp apple2499 fi

News and Trends 17 Oct 2016

It’s not over yet for Opdivo; AbbVie takes a stand in Leukemia

The Committee on Medicinal Products for Human Use (CHMP) has handed down a pair of positive opinions of Opdivo and AbbVie’s leukemia therapy in their quests for EMA approval. Before the European Commission reviews an application for market authorization, it crosses the collective desk of the Committee on Medicinal Products for Human Use (CHMP). If […]

October 17, 2016 - 2 minutesmins - By Evelyn Warner

l81

News and Trends 15 Oct 2016

This Scientist crystallises Bacteria for Stained Glass and Lace!

Simon Park is a scientist who wants to teach us about the microbiome through his art. Among his works are a self-portrait, lace and stained glass, all of which have been produced from bacteria! At Cafe Science, Dr. Simon Park, Senior Lecturer in Microbial Sciences at the University of Surrey, described the diversity and ubiquity […]

October 15, 2016 - 3 minutesmins - By Evelyn Warner

ADVERTISEMENT

Screen Shot 2016 10 13 at 16.52.32

News and Trends 14 Oct 2016

This Biotech makes DNA Vaccines and Gene Therapy Possible in Lapland

After Grenoble, we fly north to Finland to meet Santa’s reindeer and earn his good graces before Christmas. After a trip to the sauna and down time with Angry Birds, whose creator hails from the country, we moseyed over to visit FIT Biotech, our biotech of the week. City: Tampere, Finland Founded: 1995 Employees: 12 + […]

October 14, 2016 - 2 minutesmins - By Evelyn Warner

shutterstock 427253293

News and Trends 13 Oct 2016

This Start-up sells Cheap 3D-printed Microscopes for Bacterial testing

What if you could print your own microscope to save money? WaterScope has designed a 3D-printed microscope for rapid water testing in the field on a budget. WaterScope is a spin-out from the University of Cambridge that 3D prints microscopes and sells them to anyone that requires low-cost equipment for their project or start-up. The funds will […]

October 13, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

ovaries Tefi fi

News and Trends 13 Oct 2016

Adaptimmune Revises TCR Protocol following Phase I/IIa Failure

Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to include fludarabine, which was linked to deaths in Juno’s CAR-T trials. Despite optimism that T-cells are the key to cancer cures, the field has taken a number of hits this year. Most recently, the FDA put a partial hold on […]

October 13, 2016 - 2 minutesmins - By Evelyn Warner

Screenshot 2016 10 12 at 12.23.30 PM e1476267908354

News and Trends 12 Oct 2016

Transgene teams up with big Players against HPV Head and Neck Cancer

Transgene is partnering with Merck and Pfizer to develop a combined therapy for head and neck cancer squamous cell carcinoma (HNSCC) caused by human papiloma virus (HPV) infections. A successful outcome will let the team access a €2B market niche. Transgene has been struggling for a while: last year it had to fire 40% of its workforce […]

October 12, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

biobutanediol mater biotech novamont bioeconomy

News and Trends 12 Oct 2016

Italy has new €100M Factory for Biobased Butanediol

With an industry worth €3.5Bn, butanediol is an important chemical intermediate. Novamont has recently opened the first industrial plant to produce bio-butanediol from sugars, using engineered E. coli. Biotechnology is a key driver in replacing fossil fuels with renewable raw materials, so companies and academia are busy creating ways to produce different chemicals from biomass. Examples […]

October 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

shutterstock 310552094

News and Trends 12 Oct 2016

Will Aprea live up to the Hype of its €46M fundraising?

Aprea raised a huge €46M for a first-in-class drug that targets the deadliest form of ovarian cancer. The company just started Phase II trials after positive results from Phase I. But will it be able to outperform all its competitors? Aprea is a spin-out company from the Karolinska Development, the portfolio company of the Institute, in Sweden. It became […]

October 12, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT